CAB-LA May Be Superior To TDF-FTC For Preventing HIV Infection, Study Finds

HealthDay (8/12) reports on research finding that “for men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtrici...